Author | Julian Upton

Report sets out self-assessment measures for low- and middle-income countries in their adoption of new health technologies.

Anne E. White, president, Lilly Oncology, talks about how the lessons she learned from leading a startup helped her to speed Lilly’s drug development from target identification through successful launch

New hope accompanies overdue recognition in sickle cell disease fight.

As we wait for a COVID-19 vaccine, pharma is looking to blockchain technology to prepare for the major supply-chain obstacles to come.